1. Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay. Issue 7 (July 2016) Authors: Weisshof, Roni; Ungar, Bella; Blatt, Alexandra; Dahan, Aviva; Pressman, Sigal; Waterman, Matti; Kopylov, Uri; Ben-Horin, Shomron; Chowers, Yehuda Journal: Inflammatory bowel diseases Issue: Volume 22:Issue 7(2016:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD. Issue 4 (4th April 2018) Authors: Gaujoux, Renaud; Starosvetsky, Elina; Maimon, Naama; Vallania, Francesco; Bar-Yoseph, Haggai; Pressman, Sigal; Weisshof, Roni; Goren, Idan; Rabinowitz, Keren; Waterman, Matti; Yanai, Henit; Dotan, Iris; Sabo, Edmond; Chowers, Yehuda; Khatri, Purvesh; Shen-Orr, Shai S Journal: Gut Issue: Volume 68:Issue 4(2019) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients. (24th November 2021) Authors: Bar-Yoseph, Haggai; Blatt, Alexandra; Gerassy, Shiran; Pressman, Sigal; Mousa, Amjad; Sabo, Edmond; Waterman, Matti; Ungar, Bella; Ben-Horin, Shomron; Chowers, Yehuda Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 6(2022) Page Start: 884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Issue 1 (January 2019) Authors: Kopylov, Uri; Avni-Biron, Irit; Ron, Yulia; Koslowsky, Benjamin; Waterman, Matti; Daher, Saleh; Ungar, Bella; Schwartz, Doron; Zittan, Eran; Openhaim, Michal; Yanai, Henit; Maharshak, Nitsan; Bar Gil Shitrit, Ariella; Naftali, Timna; Eliakim, Rami; Chowers, Yehuda; Ben-Horin, Shomron; Dotan, Iris Journal: Digestive and liver disease Issue: Volume 51:Issue 1(2019) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Issue 3 (13th February 2017) Authors: Kopylov, Uri; Ron, Yulia; Avni-Biron, Irit; Koslowsky, Benjamin; Waterman, Matti; Daher, Saleh; Ungar, Bella; Yanai, Henit; Maharshak, Nitsan; Ben-Bassat, Ofer; Lichtenstein, Lev; Bar-Gil Shitrit, Ariella; Israeli, Eran; Schwartz, Doron; Zittan, Eran; Eliakim, Rami; Chowers, Yehuda; Ben-Horin, Sh... Journal: Inflammatory bowel diseases Issue: Volume 23:Issue 3(2017) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Issue 3 (13th February 2017) Authors: Kopylov, Uri; Ron, Yulia; Avni-Biron, Irit; Koslowsky, Benjamin; Waterman, Matti; Daher, Saleh; Ungar, Bella; Yanai, Henit; Maharshak, Nitsan; Ben-Bassat, Ofer; Lichtenstein, Lev; Bar-Gil Shitrit, Ariella; Israeli, Eran; Schwartz, Doron; Zittan, Eran; Eliakim, Rami; Chowers, Yehuda; Ben-Horin, Sh... Journal: Inflammatory bowel diseases Issue: Volume 23:Issue 3(2017) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Issue 3 (March 2017) Authors: Kopylov, Uri; Ron, Yulia; Avni-Biron, Irit; Koslowsky, Benjamin; Waterman, Matti; Daher, Saleh; Ungar, Bella; Yanai, Henit; Maharshak, Nitsan; Ben-Bassat, Ofer; Lichtenstein, Lev; Bar-Gil Shitrit, Ariella; Israeli, Eran; Schwartz, Doron; Zittan, Eran; Eliakim, Rami; Chowers, Yehuda; Ben-Horin, Sh... Journal: Inflammatory bowel diseases Issue: Volume 23:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic Predictors of Benign Course of Ulcerative Colitis—A North American Inflammatory Bowel Disease Genetics Consortium Study. Issue 10 (October 2016) Authors: Kopylov, Uri; Boucher, Gabrielle; Waterman, Matti; Rivers, Claudia R.; Patel, Mohini; Cho, Judy H.; Colombel, Jean F.; Duerr, Richard H.; Binion, David; McGovern, Dermot P. B.; Schumm, Phillip P.; Brant, Steven R.; Silverberg, Mark S.; Rioux, John D.; Bitton, Alain Journal: Inflammatory bowel diseases Issue: Volume 22:Issue 10(2016:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study. Issue 9 (5th June 2017) Authors: Kopylov, Uri; Papamichael, Konstantinos; Katsanos, Konstantinos; Waterman, Matti; Bar-Gil Shitrit, Ariella; Boysen, Trine; Portela, Francisco; Peixoto, Armando; Szilagyi, Andrew; Silva, Marco; Maconi, Giovanni; Har-Noy, Ofir; Bossuyt, Peter; Mantzaris, Gerassimos; Barreiro de Acosta, Manuel; Chap... Journal: Inflammatory bowel diseases Issue: Volume 23:Issue 9(2017) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases. Issue 1 (25th January 2022) Authors: Awadie, Halim; Waterman, Matti Journal: Journal of clinical gastroenterology Issue: Volume 56:Issue 1(2022) Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗